COMPARATIVE EFFECTIVENESS OF OSTEOPOROSIS (OP) THERAPIES AMONG A POPULATION OF POSTMENOPAUSAL (PM) WOMEN IN THE UNITED STATES (US)

被引：0
|
作者：
Kim, M. [1 ]
Mcgrath, L. [2 ]
Pritchard, D. [3 ]
Samai, P. [3 ]
Lin, T. [1 ]
Stad, R. [1 ]
Spangler, L. [1 ]
Mcdermott, M. [1 ]
Bradbury, B. [1 ]
Brookhart, M. [3 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Inferential Design LLC, Durham, NC USA
[3] NoviSci Inc, Durham, NC USA
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2022年 / 34卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P612
引用
收藏
页码：S304 / S305
页数：2
相关论文
共 50 条
  • [1] Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (US)
    Kim, Min
    McGrath, Leah J.
    Pritchard, David
    Samai, Peter
    Lin, Jay
    Stad, Robert Kees
    Spangler, Leslie
    McDermott, Michele
    Bradbury, Brian D.
    Brookhart, M. Alan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1169 - 1170
  • [2] Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
    Emily Durden
    Lionel Pinto
    Lorena Lopez-Gonzalez
    Paul Juneau
    Richard Barron
    [J]. Archives of Osteoporosis, 2017, 12
  • [3] Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
    Durden, Emily
    Pinto, Lionel
    Lopez-Gonzalez, Lorena
    Juneau, Paul
    Barron, Richard
    [J]. ARCHIVES OF OSTEOPOROSIS, 2017, 12 (01)
  • [4] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Arora, T.
    Liu, Y.
    Lin, T. -C.
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    Kim, M.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S56
  • [5] Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3979 - 3981
  • [6] Disparities in osteoporosis care among postmenopausal women in the United States
    Ruiz-Esteves, Karina N.
    Teysir, Jimmitti
    Schatoff, Daria
    Yu, Elaine W.
    Burnett-Bowie, Sherri-Ann M.
    [J]. MATURITAS, 2022, 156 : 25 - 29
  • [7] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S580 - S580
  • [8] Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Brunetti, Vanessa C.
    Lin, Tzu-Chieh
    Spangler, Leslie
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5021 - 5022
  • [9] Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert Kees
    Mcdermott, Michele
    Bradbury, Brian D.
    Kim, Min
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (07) : 826 - 834
  • [10] Preference-Based Instrumental Variable Methods in the Comparative Effectiveness of Osteoporosis (OP) Medications in Women with Postmenopausal Osteoporosis (PMO)
    Der, Jane S.
    Critchlow, Cathy
    Xue, Fei
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 31 - 31
12345